Anja Rinke
About
Anja Rinke is a scholar working on Epidemiology, Oncology and Neurology.
According to data from OpenAlex, Anja Rinke has authored 98 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Epidemiology, 86 papers in Oncology and 65 papers in Neurology. Recurrent topics in Anja Rinke's work include Neuroendocrine Tumor Research Advances (96 papers), Lung Cancer Research Studies (79 papers) and Neuroblastoma Research and Treatments (64 papers). Anja Rinke is often cited by papers focused on Neuroendocrine Tumor Research Advances (96 papers), Lung Cancer Research Studies (79 papers) and Neuroblastoma Research and Treatments (64 papers). Anja Rinke collaborates with scholars based in Germany, Italy and Netherlands. Anja Rinke's co-authors include Thomas M. Gress, Rudolf Arnold, Carmen Schade‐Brittinger, Behnaz Aminossadati, Hans‐Helge Müller, M. Wied, Klaus‐Jochen Klose, Peter Barth, Christina Mayer and Ulrich‐Frank Pape and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
In The Last Decade
Anja Rinke
92 papers receiving 4.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anja Rinke Germany | 28 | 4.4k | 4.0k | 3.2k | 222 | 193 | 98 | 4.6k | ||
| Colleen Leary United States | 8 | 3.8k 0.9× | 3.4k 0.8× | 2.5k 0.8× | 272 1.2× | 156 0.8× | 11 | 4.0k | ||
| Cecile G. Dagohoy United States | 8 | 3.6k 0.8× | 3.4k 0.8× | 2.4k 0.7× | 255 1.1× | 108 0.6× | 14 | 3.9k | ||
| Jeannette E. Mares United States | 7 | 3.6k 0.8× | 3.3k 0.8× | 2.4k 0.7× | 238 1.1× | 104 0.5× | 13 | 3.9k | ||
| Francesco Panzuto Italy | 35 | 3.2k 0.7× | 3.1k 0.8× | 1.9k 0.6× | 363 1.6× | 93 0.5× | 136 | 3.8k | ||
| Staffan Welin Sweden | 21 | 2.4k 0.5× | 2.2k 0.5× | 1.7k 0.5× | 219 1.0× | 165 0.9× | 67 | 2.7k | ||
| Jennifer A. Chan United States | 23 | 2.4k 0.5× | 2.3k 0.6× | 1.7k 0.5× | 131 0.6× | 91 0.5× | 70 | 2.6k | ||
| Jan Harder Germany | 17 | 1.8k 0.4× | 2.2k 0.6× | 1.3k 0.4× | 482 2.2× | 118 0.6× | 28 | 3.0k | ||
| Kjell E. Öberg Sweden | 19 | 1.4k 0.3× | 1.3k 0.3× | 997 0.3× | 83 0.4× | 153 0.8× | 34 | 2.2k | ||
| C. Lombard Bohas France | 6 | 1.7k 0.4× | 1.7k 0.4× | 1.2k 0.4× | 135 0.6× | 57 0.3× | 17 | 2.2k | ||
| C. Blanckmeister United States | 5 | 1.4k 0.3× | 1.5k 0.4× | 1.1k 0.3× | 72 0.3× | 35 0.2× | 8 | 1.9k |
Countries citing papers authored by Anja Rinke
Since
Specialization
Citations
This map shows the geographic impact of Anja Rinke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Rinke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Rinke more than expected).
Fields of papers citing papers by Anja Rinke
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anja Rinke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Rinke. The network helps show where Anja Rinke may publish in the future.
Co-authorship network of co-authors of Anja Rinke
This figure shows the co-authorship network connecting the top 25 collaborators of Anja Rinke. A scholar is included among the top collaborators of Anja Rinke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Rinke. Anja Rinke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bruckner, F E, et al.. (2025). Hypercalcemia due to PTHrp producing pancreas NET: A case report. International Journal of Surgery Case Reports. 128(C). 111058–111058.
2.
Wächter, Sabine, Dimitrios Panidis, Moritz Jesinghaus, et al.. (2025). Retrospective analysis of criteria for oncological completion surgery of neuroendocrine tumors of the appendix. Langenbeck s Archives of Surgery. 410(1). 46–46.
3.
Maasberg, Sebastian, Nehara Begum, Anja Rinke, et al.. (2025). Clinical characteristics and treatment patterns of patients with gastroenteropancreatic neuroendocrine neoplasia in Germany receiving peptide receptor radionuclide therapy: A real-world data registry-based study. Medicine. 104(11). e41853–e41853.
4.
Köenig, Alexander, James B. Reinecke, Kristina Lång, et al.. (2024). 1146MO Interim analysis of CABONEN: A multicenter phase II trial investigating cabozantinib in patients with advanced, low proliferative NEN G3. Annals of Oncology. 35. S752–S752.
5.
Pavel, Marianne, Harald Lahner, Dieter Hörsch, et al.. (2024). Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study. The Oncologist. 29(5). e643–e654.
6.
Weber, Matthias M., Leonidas Apostolidis, Sebastian Krug, et al.. (2023). 1185MO Activity and safety of avelumab alone or in combination with cabozantinib in patients with advanced high grade neuroendocrine neoplasias (NEN G3) progressing after chemotherapy. The phase II, open-label, multicenter AVENEC and CABOAVENEC trials. Annals of Oncology. 34. S702–S702.
7.
Rinke, Anja, Valentina Ambrosini, Clarisse Dromain, et al.. (2023). European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for colorectal neuroendocrine tumours. Journal of Neuroendocrinology. 35(6). e13309–e13309.
8.
Gress, Thomas M., et al.. (2023). Radiofrequency and microwave ablation controls hepatic oligoprogression of advanced gastroenteropancreatic neuroendocrine tumors. Journal of Neuroendocrinology. 35(6). e13289–e13289.
9.
Merola, Elettra, Aurel Perren, Anja Rinke, et al.. (2022). High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent. Journal of Neuroendocrinology. 34(10). e13193–e13193.
10.
Krug, Sebastian, Jens Walldorf, Philipp A. Reuken, et al.. (2022). The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers. 14(3). 613–613.
11.
Maurer, Elisabeth, Monika Heinzel‐Gutenbrunner, Anja Rinke, et al.. (2021). Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms. Journal of Neuroendocrinology. 34(1). e13076–e13076.
12.
Rinke, Anja, Christoph Maintz, Lothar Müller, et al.. (2021). Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria. Experimental and Clinical Endocrinology & Diabetes. 129(7). 500–509.
13.
Rinke, Anja, Christoph J. Auernhammer, Lisa Bodei, et al.. (2021). Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?. Gut. 70(9). 1768–1781.
14.
Krug, Sebastian, et al.. (2020). Professional Assessment of the Impact of COVID-19 on Handling NET Patients. Journal of Clinical Medicine. 9(11). 3633–3633.
15.
Breitling, Lutz Philipp, Anja Rinke, & Thomas M. Gress. (2019). Recent Survival Trends in High-Grade Neuroendocrine Neoplasms and Lung Cancer. Neuroendocrinology. 110(3-4). 225–233.
16.
García‐Carbonero, Rocio, Anja Rinke, Juan W. Valle, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy. Neuroendocrinology. 105(3). 281–294.
17.
Pavel, Marianne, Juan W. Valle, Barbro Eriksson, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology. 105(3). 266–280.
18.
Kaltsas, Gregory, Martyn Caplin, Philippa Davies, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors. Neuroendocrinology. 105(3). 245–254.
19.
Krug, Sebastian, Thomas M. Gress, Patrick Michl, & Anja Rinke. (2017). The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors. Digestion. 96(2). 67–75.
20.
Rinke, Anja, Hans‐Helge Müller, Carmen Schade‐Brittinger, et al.. (2009). Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group. Journal of Clinical Oncology. 27(28). 4656–4663.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Colleen Leary Breakdown of academic impact, for papers by Cecile G. Dagohoy Breakdown of academic impact, for papers by Jeannette E. Mares Breakdown of academic impact, for papers by Francesco Panzuto Breakdown of academic impact, for papers by Staffan Welin Breakdown of academic impact, for papers by Jennifer A. Chan Breakdown of academic impact, for papers by Jan Harder Breakdown of academic impact, for papers by Kjell E. Öberg Breakdown of academic impact, for papers by C. Lombard Bohas Breakdown of academic impact, for papers by C. Blanckmeister